Because CCR4 is preferentially expressed on Th2 cells, TARC has been associated with Th2-dominant skin diseases, including atopic dermatitis, bullous pemphigoid, and cutaneous T-cell lymphoma [18,19,20]. Here, CCR4 is linked to atopic eczema.